Alberta Blue Cross's 2026 drug pipeline report says GLP-1 receptor agonists remain a major cost driver for private plans and that overall GLP-1 therapy plan spend is unlikely to decline in future years, even as a semaglutide generic is expected in mid-2026 [Source: ab.bluecross.ca/plans/group/drug-pipeline-2026.php]
Lyophilized peptides are typically stable at room temperature for weeks, but refrigeration is preferred to extend stability
2021Y06), Heilongjiang Postdoctoral Scientific Research Developmental Fund (Grant No
L-carnitine itself, as well as several of its metabolites, including GBB, crotonobetaine, and trimethylamine-n-oxide (TMAO), have been associated with cerebrovascular dysfunction and cardiovascular disease (Koeth et al., 2013, 2014, 2019
We finally emphasize the promising therapeutic potential of HGF and HGF mimetics enlightened by a panel of animal models and by the first human clinical trials